Lamotrigine in two cases of Rett syndrome

Brain and Development

Volumn 23, Issue 4, 2001, Pages 240-242

  Kumandas, Sefer ^a   Çaksen, Hüseyin ^a   Çiftçi, Ahmet ^a   Öztürk, Mustafa ^a   Per, Hüseyin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Lamotrigine; Rett syndrome

Indexed keywords

LAMOTRIGINE; PHENOBARBITAL; VALPROIC ACID;

ARTICLE; AUTISM; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; CONVULSION; FEMALE; HAND MOVEMENT; HUMAN; LANGUAGE DISABILITY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PSYCHOMOTOR DEVELOPMENT; RETT SYNDROME; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

ANTICONVULSANTS; CHILD, PRESCHOOL; FEMALE; HUMANS; RETT SYNDROME; TRIAZINES;

EID: 0035000091     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00191-7     Document Type: Article

References (20)

1. Rett A. Über ein eigenartiges hirnatrophisches syndrom bei hyperammoniamie in Kindesalter. Wien Med Wochens. 116:1966;378-723. (cited in ref. 2).
2. Hagberg B.A., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 14:1983;471-479.
3. Haslam R.H.A. The nervous system. Behrman R.E., Kliegman R.M., Jenson H.B. Textbook of pediatrics. 16th ed :2000;1793-1866 WB Saunders, Philadelphia.
4. Segawa M. Possible lesions of the Rett syndrome: opinions of contributors. Brain Dev. 14:1992;S149-S150.
5. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 23:1999;185-188.
6. Uldall P., Hansen F.J., Tonnby B. Lamotrigine in Rett syndrome. Neuropediatrics. 24:1993;339-340.
7. Hamberger A., Gillberg C., Palm A., Hagberg B. Elevated CSF glutamate in Rett syndrome. Neuropediatrics. 23:1992;212-213.
8. Leach M.F., Baxter M.G., Chritchley A.E. Neurochemical and behavioral aspects of Lamotrigine. Epilepsy. 32:(Suppl 2):1991;4-8.
9. Krageloh-Mann I., Schroth G., Niemann G., Michaelis R. The Rett syndrome: magnetic resonance imaging and clinical findings in four girls. Brain Dev. 11:1989;175-178.
10. Nielsen J.B., Toft P.B., Reske-Nielsen E., Jensen K.E., Christiansen P., Thomsen C., et al. Cerebral magnetic resonance spectroscopy in Rett syndrome failure to detect mitochondrial disorder. Brain Dev. 15:1992;107-112.
11. Murakami J.W., Courhesne E., Haas R.H., Press G.A., Yeung-Courhesne R. Cerebellar and cerebral abnormalities in Rett syndrome: a quantitative MR analysis. AJR. 159:1992;177-183.
12. Percy A.K., Glaze D.G., Schultz R.J., Zoghbi H.Y., Williamson D., Frost J.D., et al. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 35:1994;464-470.
13. Zappella M. A double blind trial of bromocriptine in the Rett syndrome. Brain Dev. 12:1990;148-150.
14. Zappella M., Genazzani A., Facchinetti F., Hayek G. Bromocriptine in the Rett syndrome. Brain Dev. 12:1990;221-225.
15. Nielson J.B., Lou H.C., Andresen J. Biochemical and clinical effects of tyrosine and tryptophan in Rett syndrome. Brain Dev. 12:1990;143-147.
16. Egger J., Hofacker N., Schiel W., Holthausen H. Magnesium for hyperventilation in Rett's syndrome. Lancet. 340:1992;621-622.
17. Nomura Y., Segawa M., Higurashi M. Rett syndrome - an early catecholamine and indolamine deficient disorder? Brain Dev. 7:1985;334-341.
18. Segawa M. Pathophysiology of Rett syndrome from the standpoint of early catecholamine disturbance. Eur Child Adolesc Psychiatry. 6:(Suppl 1):1997;56-60.
19. Pelligra R., Norton R.D., Wilkinson R., Leon H.A., Watson W.R. Rett syndrome: Stimulation of endogenous biogenic amines. Neuropediatrics. 23:1992;131-137.
20. Percy A.K. Neurochemistry of the Rett syndrome. Brain Dev. 14:1992;S57-S62.